Eli Lilly announced the results of a clinical trial for its new pill, which the company said causes nearly 8% weight loss at ...

BMO Capital analyst Ketan Mamtora downgraded Beacon (BECN) to Market Perform from Outperform with a price target of $124.35, down from $130.

BMO Capital reinstated coverage of Newmont (NEM) with an Outperform rating and $63 price target Following a transformative year, Newmont is ...

Ivanhoe Electric (TSX, NYSE: IE) said the United States export credit agency is interested in lending it up to $825 million ...